Jamil Muqtadir Bhatti , Syed Ali Raza , Fatima Zaina , Syed Ali Abbas , Irshad Batool , Muhammad Owais Shahid , Nazish Hussain
{"title":"COVID-19 重症患者中致命的 CMV 肺炎--4 例患者的系列病例","authors":"Jamil Muqtadir Bhatti , Syed Ali Raza , Fatima Zaina , Syed Ali Abbas , Irshad Batool , Muhammad Owais Shahid , Nazish Hussain","doi":"10.1016/j.hmedic.2024.100062","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The SARS-CoV-2 epidemic has wreaked havoc on the world's leading healthcare systems, especially in intensive care. While cytomegalovirus (CMV) co-infections are widespread in severely ill patients because of an underlying immune suppression brought on by various causes, their influence on patients riddled with COVID-19 is unknown. Nevertheless, there is a correlation between severe COVID-19 and significant immune suppression, which has an impact on the reactivation of the coronavirus (CMV) and subsequently affects the clinical outcome.</p></div><div><h3>Case presentation</h3><p>The authors provide a case series of four patients with severe COVID-19-related respiratory failure referred to a high dependency unit (HDU). During their stay in the HDU, all the patients acquired CMV reactivation.</p></div><div><h3>Conclusion</h3><p>COVID pneumonia and immunosuppressants are used to suppress cytokine storms, but they can also play a role in CMV reactivation and its implications for fatal outcomes.</p></div>","PeriodicalId":100908,"journal":{"name":"Medical Reports","volume":"5 ","pages":"Article 100062"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949918624000275/pdfft?md5=5cb621df4b1216cd810063f3824365e9&pid=1-s2.0-S2949918624000275-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Fatal CMV pneumonitis in critically ill COVID-19 patient–A case series of 4 patient\",\"authors\":\"Jamil Muqtadir Bhatti , Syed Ali Raza , Fatima Zaina , Syed Ali Abbas , Irshad Batool , Muhammad Owais Shahid , Nazish Hussain\",\"doi\":\"10.1016/j.hmedic.2024.100062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>The SARS-CoV-2 epidemic has wreaked havoc on the world's leading healthcare systems, especially in intensive care. While cytomegalovirus (CMV) co-infections are widespread in severely ill patients because of an underlying immune suppression brought on by various causes, their influence on patients riddled with COVID-19 is unknown. Nevertheless, there is a correlation between severe COVID-19 and significant immune suppression, which has an impact on the reactivation of the coronavirus (CMV) and subsequently affects the clinical outcome.</p></div><div><h3>Case presentation</h3><p>The authors provide a case series of four patients with severe COVID-19-related respiratory failure referred to a high dependency unit (HDU). During their stay in the HDU, all the patients acquired CMV reactivation.</p></div><div><h3>Conclusion</h3><p>COVID pneumonia and immunosuppressants are used to suppress cytokine storms, but they can also play a role in CMV reactivation and its implications for fatal outcomes.</p></div>\",\"PeriodicalId\":100908,\"journal\":{\"name\":\"Medical Reports\",\"volume\":\"5 \",\"pages\":\"Article 100062\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949918624000275/pdfft?md5=5cb621df4b1216cd810063f3824365e9&pid=1-s2.0-S2949918624000275-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949918624000275\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949918624000275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Fatal CMV pneumonitis in critically ill COVID-19 patient–A case series of 4 patient
Background
The SARS-CoV-2 epidemic has wreaked havoc on the world's leading healthcare systems, especially in intensive care. While cytomegalovirus (CMV) co-infections are widespread in severely ill patients because of an underlying immune suppression brought on by various causes, their influence on patients riddled with COVID-19 is unknown. Nevertheless, there is a correlation between severe COVID-19 and significant immune suppression, which has an impact on the reactivation of the coronavirus (CMV) and subsequently affects the clinical outcome.
Case presentation
The authors provide a case series of four patients with severe COVID-19-related respiratory failure referred to a high dependency unit (HDU). During their stay in the HDU, all the patients acquired CMV reactivation.
Conclusion
COVID pneumonia and immunosuppressants are used to suppress cytokine storms, but they can also play a role in CMV reactivation and its implications for fatal outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
